Xiangdong Liu

Title: Innovations of Xiangdong Liu in Cancer Treatment

Introduction

Xiangdong Liu is a notable inventor based in Metuchen, NJ, who has made significant contributions to the field of cancer treatment. He holds two patents that focus on innovative methods and compositions related to HER-2 cleavage, which is crucial in the fight against breast cancer.

Latest Patents

His latest patents include compositions, methods, and kits that are based on the ADAM-mediated cleavage of HER-2. These inventions aim to provide treatments for cancer, particularly breast cancer, by modulating the cleavage of HER-2. The patents also explore the synergistic effects of inhibiting HER-2 cleavage by an ADAM in conjunction with certain cytostatic and cytotoxic compounds, such as Herceptin and Taxol. Additionally, he has identified and isolated novel variants of ADAM15, designated as ADAM15 variant 1 and ADAM15 variant 2.

Career Highlights

Xiangdong Liu has worked with prominent companies in the biotechnology sector, including Incyte Corporation and Incyte Holdings Corporation. His work has been instrumental in advancing cancer research and treatment methodologies.

Collaborations

Some of his notable coworkers include Steven M. Friedman and Peggy Ann Scherle, who have contributed to his research endeavors.

Conclusion

Xiangdong Liu's innovative work in the field of cancer treatment through his patents on HER-2 cleavage showcases his commitment to improving therapeutic options for patients. His contributions are vital in the ongoing battle against breast cancer.